Covidien COV
-
Why Buying 'Market Outperform' Zalicus At A Discount Is Savvy
By James Stocklasar Thomas Jr. : Here is Zalicus ( ZLCS ) at a discount. Recent 12 Month Low $0.72/share closing at $0.77/share (18 May 2012) Breaking its previous mid-80 cent low, Zalicus has fallen, but on the heels of ZERO negative news. Zalicus has simply fallen because the market is bearish.
-
New Issue- Covidien Int'l Finance sells $1.25 bln in 2 parts
May 22 (Reuters) - Covidien International Finance SA on Tuesday sold $1.25 billion of notes ..... Bank were the joint bookrunning managers for the sale. BORROWER: COVIDIEN INTERNATIONAL FINANCE TRANCHE 1 AMT $600 MLN COUPON 1.35 PCT MATURITY …
-
Feeling A Little Better About The Growth/Value Proposition At Medtronic
By Stephen Simpson : Med-tech isn't much different than any other sector of the market; when the growth goes, so do the investors. While the widespread slowdowns in multiple key businesses have definitely dented Medtronic's ( MDT ) recent growth, it's not as though the stock may seem to be an ...
-
COVIDIENFINANCEINTERNATIONAL/BRIEF (URGENT)
May 22 (Reuters) - Covidien Finance International SA: * Moodys assigns baa1 rating to covidiens new senior note offering; stable
-
TEXT-Fitch rates Covidien's proposed notes 'A'
May 22 - Fitch Ratings has assigned an 'A' rating to Covidien International Finance S.A.'s (CIFSA) proposed senior unsecured notes. Proceeds will be used to refinance the $500 million senior...
-
VHT Vanguard Health Care ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… UNH and WellPoint WLP, biotech companies such as Amgen AMGN, and medical-device firms such as Medtronic MDT and Covidien COV . The fund's heavy exposure to Big Pharma shouldn't by itself deter investors because the subsector weightings are …
-
TEXT-S&P rates Covidien PLC's notes 'A'
… rating to Mansfield, Mass.-based Covidien PLC's benchmark issuance of unsecured ..... tranches. The debt will be issued by Covidien International Finance S.A., a Luxembourg ..... all of the operating subsidiaries of Covidien PLC. Covidien International is the primary …
-
An Exciting New Technology That Could Take Pressure Off St. Jude Medical
By Alan Brochstein , CFA: Renal denervation. This is something I had never heard about until St. Jude Medical ( STJ ) mentioned it at their February analyst day after first disclosing it in late 2011 ( press release ). As I include STJ in my Top 20 Model Portfolio , it caught my attention a few ...
-
St Jude is latest to launch blood pressure device
* Joins Medtronic, Covidien selling such devices in Europe
-
Can Teva Win With The Big Pharma Playbook?
… measure, a few outliers like Endo Pharmaceuticals ( ENDP ) add devices to the mix, while others like Abbott ( ABT ) and Covidien ( COV ) look to split and spin-off their drug businesses. What's the point? Well, mostly that Teva probably has to …